Lexxel tablets to be discontinued

AstraZeneca has decided to discontinue the manufacturing and distribution of Lexxel (enalapril maleate-felodipine ER) tablets on July 31, 2008. Lexxel is indicated for the treatment of hypertension.

For more information call (800) 236-9933 or visit www.fda.gov/cder/drug/shortages/default.htm#LEXXEL.